Stonhard Cures Purepac Pharmaceuticals’ Flooring Problems In 1995, the market for generic drugs was valued at $11.8 billion. This industry is expected to continue its healthy growth by increasing at a rate of 23% through the year 2000. It’s easy to see that manufacturers of generic drugs have found their niche within the strong pharmaceutical market. And so has Stonhard. Pharmaceutical manufacturers currently represent 5.6% of Stonhard’s total cu

Join for free to read